Continuing its trend of doing business with suppliers who make equity investments, GeneProt last week announced it had signed an agreement with Zymark to buy four of its automated protein digestion and spotting systems. In return, Zymark committed itself to making an undisclosed equity investment in North Brunswick, NJ-based GeneProt.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.